Dihydrostreptomycin has 2 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Pyridostigmine Bromide, Vecuronium Bromide. Patients taking Dihydrostreptomycin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Major
- 2
Major (2)
- Dihydrostreptomycin + Pyridostigmine Bromide— Parenteral administration may intensify or produce neuromuscular block and paralysis when used with pyridostigmine.
- Dihydrostreptomycin + Vecuronium Bromide— Dihydrostreptomycin may intensify or produce neuromuscular block on its own and can cause unexpected prolongation of vec…